Chief Growth Officer

Rodney Kelly has extensive international experience in health innovation, with a strong emphasis on improving patient outcomes and enabling market access across the UK, Japan, and Southeast Asia. He supports health and life sciences ventures through clinical validation, regulatory navigation, and global expansion, helping them align with local healthcare system demands.

He has advised hundreds of early and growth-stage health tech companies, offering strategic guidance on partnerships, financial planning, and policy engagement. His work spans aging, digital health and chronic disease management, contributing to the delivery of advanced care models tailored to real-world needs.

Rodney has created collaborative platforms that bring together stakeholders from public and private sectors, enabling knowledge exchange and cross-border innovation. He focuses on ensuring new technologies reach patients efficiently by supporting evidence generation, investment readiness, and regulatory pathways.

His efforts have helped companies scale globally, access underserved populations, and collaborate with healthcare providers and insurers. By working closely with governments, he has contributed to building sustainable ecosystems that accelerate innovation adoption and improve healthcare delivery worldwide.